Catalyst Wire Dossier Catalyst Wire Dossier

Transdermal Continuous Oxygen Therapy

· Neogenix, LLC dba Ogenix
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Transdermal Continuous Oxygen Therapy, covering 2014-05-13 to 2017-08-14. Get the full timeline:

Most recent: Clinical Trial Update: Transdermal Continuous Oxygen Therapy for Infection Prophylaxis in High- Risk Patients Undergoing Instrumented Fusion [NA]

See pricing